Cargando…

Preliminary Analysis of Cervical Cancer Immunotherapy

Cervical cancer is one of the most common gynecologically malignancies worldwide. Although vaccine and cervical cancer screening including human papillomavirus testing, cytology testing, and colposcopy have developed rapidly in recent years, effectively reducing cervical cancer mortality, cervical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhen, Zou, Xinxin, Yan, Zhaohua, Chen, Caiyun, Chen, Yumei, Fu, Aizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624377/
https://www.ncbi.nlm.nih.gov/pubmed/36301242
http://dx.doi.org/10.1097/COC.0000000000000950
_version_ 1784822221744635904
author Ma, Zhen
Zou, Xinxin
Yan, Zhaohua
Chen, Caiyun
Chen, Yumei
Fu, Aizhen
author_facet Ma, Zhen
Zou, Xinxin
Yan, Zhaohua
Chen, Caiyun
Chen, Yumei
Fu, Aizhen
author_sort Ma, Zhen
collection PubMed
description Cervical cancer is one of the most common gynecologically malignancies worldwide. Although vaccine and cervical cancer screening including human papillomavirus testing, cytology testing, and colposcopy have developed rapidly in recent years, effectively reducing cervical cancer mortality, cervical cancer remains a malignancy with higher female fatality rates worldwide and has a high risk for socioeconomically disadvantaged groups. The combination of platinum-paclitaxel and chemotherapy, possibly with the addition of bevacizumab, is currently the treatment of choice for advanced cervical cancer, but it only has remission purposes. Therefore, new therapeutic strategies are needed for both locally advanced and metastatic cervical cancer. Here, we make a preliminary analysis of cervical cancer immunotherapy.
format Online
Article
Text
id pubmed-9624377
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96243772022-11-04 Preliminary Analysis of Cervical Cancer Immunotherapy Ma, Zhen Zou, Xinxin Yan, Zhaohua Chen, Caiyun Chen, Yumei Fu, Aizhen Am J Clin Oncol Review Article Cervical cancer is one of the most common gynecologically malignancies worldwide. Although vaccine and cervical cancer screening including human papillomavirus testing, cytology testing, and colposcopy have developed rapidly in recent years, effectively reducing cervical cancer mortality, cervical cancer remains a malignancy with higher female fatality rates worldwide and has a high risk for socioeconomically disadvantaged groups. The combination of platinum-paclitaxel and chemotherapy, possibly with the addition of bevacizumab, is currently the treatment of choice for advanced cervical cancer, but it only has remission purposes. Therefore, new therapeutic strategies are needed for both locally advanced and metastatic cervical cancer. Here, we make a preliminary analysis of cervical cancer immunotherapy. Lippincott Williams & Wilkins 2022-11 2022-10-26 /pmc/articles/PMC9624377/ /pubmed/36301242 http://dx.doi.org/10.1097/COC.0000000000000950 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review Article
Ma, Zhen
Zou, Xinxin
Yan, Zhaohua
Chen, Caiyun
Chen, Yumei
Fu, Aizhen
Preliminary Analysis of Cervical Cancer Immunotherapy
title Preliminary Analysis of Cervical Cancer Immunotherapy
title_full Preliminary Analysis of Cervical Cancer Immunotherapy
title_fullStr Preliminary Analysis of Cervical Cancer Immunotherapy
title_full_unstemmed Preliminary Analysis of Cervical Cancer Immunotherapy
title_short Preliminary Analysis of Cervical Cancer Immunotherapy
title_sort preliminary analysis of cervical cancer immunotherapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624377/
https://www.ncbi.nlm.nih.gov/pubmed/36301242
http://dx.doi.org/10.1097/COC.0000000000000950
work_keys_str_mv AT mazhen preliminaryanalysisofcervicalcancerimmunotherapy
AT zouxinxin preliminaryanalysisofcervicalcancerimmunotherapy
AT yanzhaohua preliminaryanalysisofcervicalcancerimmunotherapy
AT chencaiyun preliminaryanalysisofcervicalcancerimmunotherapy
AT chenyumei preliminaryanalysisofcervicalcancerimmunotherapy
AT fuaizhen preliminaryanalysisofcervicalcancerimmunotherapy